Gts Securities LLC Moon Lake Immunotherapeutics Call Options Transaction History

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$40.15 - $55.4 $602,250 - $831,000
15,000 New
15,000 $756,000
Q1 2024

May 15, 2024
BUY
$43.78 - $63.86 $332,728 - $485,336
7,600 Added 91.57%
15,900 $798,000
Q4 2023

Feb 14, 2024
BUY
$36.35 - $63.02 $14,540 - $25,208
400 Added 5.06%
8,300 $501,000
Q3 2023

Nov 15, 2023
BUY
$48.35 - $61.26 $381,965 - $483,954
7,900 New
7,900 $450,000

Others Institutions Holding MLTX

# of Institutions
124
Shares Held
58.2M
Call Options Held
52.2K
Put Options Held
38K
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.82B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email